Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire June 02, 2025 BOSTON, June 02, 2025 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on May 30, 2025, the company granted equity awards to four new employees, pursuant to the […]
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire June 02, 2025 BOSTON, June 02, 2025 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on May 30, 2025, the company issued inducement awards to
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire June 02, 2025 CAMBRIDGE, Mass., June 02, 2025 (GLOBE NEWSWIRE) — Akebia Therapeutics(R), Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted three newly-hired employees options to purchase an aggregate of 137,000 shares
Cardiff Oncology Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel in Metastatic Triple-Negative Breast Cancer Presented at ASCO 2025 GlobeNewswire June 02, 2025 – Results from Phase 1b clinical trial evaluating onvansertib + paclitaxel for metastatic triple negative breast cancer demonstrated 40% objective response rate – – The trial evaluated three
Oxbridge / SurancePlus to Attend Money20/20 Europe in Amsterdam GlobeNewswire June 02, 2025 GRAND CAYMAN, Cayman Islands, June 02, 2025 (GLOBE NEWSWIRE) — Oxbridge Re Holdings Limited (Nasdaq: OXBR) (“Oxbridge Re”), together with its subsidiary SurancePlus, is engaged in the tokenization of Real-World Assets (“RWAs”), initially with tokenized reinsurance securities and in providing reinsurance solutions
Superior Group of Companies to Participate in the D.A. Davidson Technology & Consumer Conference GlobeNewswire June 02, 2025 ST. PETERSBURG, Fla., June 02, 2025 (GLOBE NEWSWIRE) — Superior Group of Companies, Inc. (NASDAQ: SGC) today announced that Chairman, President and Chief Executive Officer, Michael Benstock, and Chief Financial Officer, Mike Koempel, will attend the Inaugural
See the original article on GunsAmerica Digest. What happens when you legally buy a rifle during a court-ordered injunction, only to be told a year later you're now a criminal for owning it? If you live in Illinois, buckle up. https://mma.prnewswire.com/media/2699168/guns_america_text_logo_Logo.jpg Washington Gun Law's William Kirk just broke down a bombshell ruling in the case-an
(NasdaqGM:TARA), NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of William “Bill” Conkling as Chief Commercial Officer. He brings more than two decades of experience developing and commercializing novel cancer and rare
Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer GlobeNewswire June 02, 2025 NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of William “Bill” Conkling as Chief Commercial Officer. He
(NASDAQ:CCBG), TALLAHASSEE, Fla., June 02, 2025 (GLOBE NEWSWIRE) — The board of directors of Capital City Bank Group (NASDAQ: CCBG) announced today that Bethany Corum has been named president of Capital City Bank, effective as of July 1, 2025. This historic appointment takes place during the Bank's landmark 130th anniversary year and marks a significant